OTCMKTS:NNCSF Nanosonics (NNCSF) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free NNCSF Stock Alerts $1.87 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$1.87▼$1.8750-Day Range$1.81▼$1.8852-Week Range$1.81▼$3.78VolumeN/AAverage Volume5,873 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Nanosonics alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Nanosonics Stock (OTCMKTS:NNCSF)Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.Read More NNCSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NNCSF Stock News HeadlinesFebruary 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX) and Nanosonics Limited (OtherNNCSF)February 27, 2024 | msn.comNanosonics reports 1H resultsApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.January 31, 2024 | markets.businessinsider.comNanosonics Limited (NNCSF) Gets a Hold from RBC CapitalJanuary 13, 2024 | forbes.comBest Online Nutritionist Certifications Of 2024January 3, 2024 | seekingalpha.comProject $1M: 2023 ReviewDecember 13, 2023 | seekingalpha.comCCBVX T. Rowe Price Large Cap Growth Portfolio Class AAugust 24, 2023 | markets.businessinsider.comNanosonics Limited (NNCSF) Gets a Buy from WilsonsApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.August 22, 2023 | markets.businessinsider.comMorgans Sticks to Its Buy Rating for Nanosonics Limited (NNCSF)August 22, 2023 | markets.businessinsider.comCiti Sticks to Their Sell Rating for Nanosonics Limited (NNCSF)July 4, 2023 | markets.businessinsider.comBell Potter Sticks to Their Sell Rating for Nanosonics Limited (NNCSF)May 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Nanosonics Limited (OtherNNCSF), Lifestance Health Group (LFST) and Verve Therapeutics (VERV)April 14, 2023 | markets.businessinsider.comJ.P. Morgan Keeps Their Hold Rating on Nanosonics Limited (NNCSF)January 24, 2023 | markets.businessinsider.comWilsons downgrades Nanosonics Limited (NNCSF) to a HoldJanuary 24, 2023 | markets.businessinsider.comBell Potter downgrades Nanosonics Limited (NNCSF) to a SellJanuary 19, 2023 | msn.comNanosonics share price leaps 9% on booming earnings in the first halfAugust 23, 2022 | seekingalpha.comNanosonics Limited's (NNCSF) CEO Michael Kavanagh on Q4 2022 Results - Earnings Call TranscriptAugust 23, 2022 | seekingalpha.comNanosonics Limited (NNCSF) CEO Michael Kavanagh on Q4 2022 Results - Earnings Call TranscriptJuly 8, 2022 | benzinga.comNanosonics (OTC:NNCSF), Earnings Estimates, EPS, and RevenueMay 24, 2022 | fool.com.auNanosonics share price slides lower on business updateFebruary 8, 2022 | nasdaq.comNNCSF After-Hours QuotesJanuary 26, 2022 | finance.yahoo.comA Look At The Fair Value Of Nanosonics Limited (ASX:NAN)October 21, 2021 | msn.comBroker upgrades Nanosonics (ASX:NAB) share price to a buy ratingSeptember 26, 2021 | finance.yahoo.comThose who invested in Nanosonics (ASX:NAN) five years ago are up 91%September 2, 2021 | msn.comThe Nanosonics (ASX:NAN) share price rocketed 25% higher in AugustAugust 24, 2021 | msn.comNanosonics (ASX:NAN) share price up 28% after earnings beat and new product announcementSee More Headlines Receive NNCSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanosonics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:NNCSF CUSIPN/A CIKN/A Webwww.nanosonics.com.au Phone(128) 063-1600FaxN/AEmployees482Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Michael C. Kavanagh BScM.B.A., CEO, President, MD & Executive DirectorMr. Rod Lopez M.B.A.COO & Regional President for Asia PacificDr. Steven Farrugia B.E.Ph.D., Chief Technology OfficerJason BurrissChief Financial OfficerMr. Sunny PillaiChief Information OfficerMr. Matthew Carbines B.Com.L.L.B., General Counsel & Company SecretaryMr. Matthew Lipscombe B.E.B.Sc., M.B.A., Chief Marketing OfficerMs. Jodi Sampson M.B.A.Chief People & Culture OfficerMr. Vincent WangHead of Global Customer Support & Technical ServicesMr. Keith Koby BSEETMBA, Senior Vice President of Sales - North AmericaMore ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors NNCSF Stock Analysis - Frequently Asked Questions Should I buy or sell Nanosonics stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nanosonics in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NNCSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NNCSF, but not buy additional shares or sell existing shares. View NNCSF analyst ratings or view top-rated stocks. How have NNCSF shares performed in 2024? Nanosonics' stock was trading at $2.84 on January 1st, 2024. Since then, NNCSF stock has decreased by 34.2% and is now trading at $1.87. View the best growth stocks for 2024 here. Are investors shorting Nanosonics? Nanosonics saw a decline in short interest in April. As of April 15th, there was short interest totaling 177,700 shares, a decline of 89.1% from the March 31st total of 1,623,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. View Nanosonics' Short Interest. How do I buy shares of Nanosonics? Shares of NNCSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NNCSF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanosonics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
